SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-044664
Filing Date
2024-02-23
Accepted
2024-02-23 17:12:11
Documents
16
Period of Report
2024-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d780237d8k.htm   iXBRL 8-K 32323
2 EX-5.1 d780237dex51.htm EX-5.1 9433
6 GRAPHIC g780237g0223032744636.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-044664.txt   176694

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eq-20240223.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20240223_lab.xml EX-101.LAB 18757
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20240223_pre.xml EX-101.PRE 11710
18 EXTRACTED XBRL INSTANCE DOCUMENT d780237d8k_htm.xml XML 3795
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 24672539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)